Michael John Costanzo
27Patents
7h-index
19Co-inventors
66Inventor score
Filing activity: Apr 28, 1992 → Nov 12, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6323219A | Methods for treating immunomediated inflammatory disorders | Human Necessities | 65 | Expired |
| US5523308A | Peptidyl heterocycles useful in the treatment of thrombin related disorders | Human Necessities | 59 | Expired |
| US5242942A | Anticonvulsant fructopyranose cyclic sulfites and sulfates | Chemistry; Metallurgy | 50 | Expired |
| US5384327A | Anticonvulsant sorbopyranose sulfamates | Chemistry; Metallurgy | 47 | Expired |
| US5827866A | Peptidyl heterocycles useful in the treatment of thrombin related disorders | Human Necessities | 12 | Expired |
| US6469036B1 | Peptidyl heterocyclic ketones useful as tryptase inhibitors | Chemistry; Metallurgy | 9 | Expired |
| US6069254A | Carboxamide derivatives of piperidine for the treatment of thrombosis disorders | Chemistry; Metallurgy | 8 | Expired |
| US5827860A | Peptidyl heterocycles useful in the treatment of thrombin related disorders | Human Necessities | 3 | Expired |
| US10239864B2 | 2-H-indazole derivatives as cyclin-dependent kinase (CDK) inhibitors and therapeutic uses thereof | Human Necessities | 3 | Active |
| US9878994B2 | 2-H-indazole derivatives as cyclin-dependent kinase (CDK) inhibitors and therapeutic uses thereof | Human Necessities | 3 | Active |
| US8158792B2 | Spiropiperidines for use as tryptase inhibitors | Chemistry; Metallurgy | 2 | Active |
| US10590111B2 | Substituted 2-anilinopyrimidine derivatives as EGFR modulators | Chemistry; Metallurgy | 1 | Active |
| US7132418B2 | Peptidyl heterocyclic ketones useful as tryptase inhibitors | Chemistry; Metallurgy | 1 | Expired |
| US7825110B2 | Substituted spiroheterocycles | Human Necessities | 1 | Active |
| US6495523B1 | Tricyclic monosaccharide derivatives useful in treating acute ischemia-induced neurodegeneration | Chemistry; Metallurgy | 0 | Expired |
| US11052086B2 | 2-anilinopyrimidine derivatives as therapeutic agents for treatment of brain cancers | Human Necessities | 0 | Active |
| US8536189B2 | Spiropiperidines for use as tryptase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US7825111B2 | Substituted spiroheterocycles | Human Necessities | 0 | Active |
| US11414401B2 | Substituted 2-anilinopyrimidine derivatives as EGFR modulators | Chemistry; Metallurgy | 0 | Active |
| US12187707B2 | Pharmaceutical formulations of N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylaminde and salts thereof | Chemistry; Metallurgy | 0 | Active |
| US7718673B2 | Isonipecotamides for the treatment of integrin-mediated disorders | Chemistry; Metallurgy | 0 | Expired |
| US11180478B2 | Pharmaceutical formulations of N-(2-(2-(dimethylamino) ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide and salts thereof | Chemistry; Metallurgy | 0 | Active |
| US11352341B2 | 2H-indazole derivatives as CDK4 and CDK6 inhibitors and therapeutic uses thereof | Human Necessities | 0 | Active |
| US7081460B2 | Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders | Chemistry; Metallurgy | 0 | Expired |
| US12258365B2 | Organophosphorus-substituted compounds as c-MET inhibitors and therapeutic uses thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.